Several Long-Evans rat substrains carrying the phenotype of oculocutaneous albinism and bleeding diathesis are a rat model of Hermansky-Pudlak syndrome (HPS). The mutation responsible for the phenotype (Ruby) was identified as a point mutation in the initiation codon of Rab38 small GTPase that regulates intracellular vesicle transport. As patients with HPS often develop life-limiting interstitial pneumonia accompanied by abnormal morphology of alveolar type II cells, we investigated lung surfactant system in Long-Evans Cinnamon rats, one strain of the Ruby rats. The lungs showed conspicuous morphology of type II cells containing markedly enlarged lamellar bodies. Surfactant phosphatidylcholine and surfactant protein B were increased in lung tissues and lamellar bodies but not in alveolar lumen. Expression levels of mRNA for surfactant proteins A, B, C, and D were not altered. Isolated type II cells showed aberrant secretory pattern of newly synthesized [ 3 H]phosphatidylcholine, i.e., decreased basal secretion and remarkably amplified agonist-induced secretion.
HERMANSKY-PUDLAK SYNDROME (HPS) is a rare autosomal recessive disorder resulting from abnormal trafficking relating to lysosome-related organelles such as melanosomes, platelet dense granules, and lamellar bodies in alveolar type II cells (10, 29) . HPS is clinically characterized by oculocutaneous albinism, bleeding diathesis, and, based on its genetic background, additional abnormalities such as progressive interstitial pneumonia. Interstitial pneumonia is the most serious complication arising in patients with HPS and has no effective therapy and is generally fatal by middle age. The lung histology show interstitial pneumonia characterized by enlarged alveolar type II cells that are fulfilled with giant lamellar bodies containing prominently increased surfactant phospholipids (16) . It is possible that lung surfactant abnormalities may be closely related to lung pathology in HPS lungs.
Several Long-Evans (LE) substrains including Fawn-hooded (FH) and Tester-Moriyama (TM) rats show oculocutaneous albinism and bleeding diathesis and hence are considered to be rat models of human HPS. The responsible gene Ruby was recently identified as Rab38 (18) , a member of the Rab small GTPase family that regulates intracellular vesicle transport. A point mutation found in the initiation codon of Rab38 has been assumed to cause null translation of the protein. LE Cinnamon (LEC) rats, which carry ATP7B gene mutation and have been used as a rat model of Wilson disease (31) , have also been identified as Ruby rats that harbor the Rab38 mutation (18) . Thus Rab38 has been nominated as another candidate gene for human HPS (5) , yet lung disease possibly occurring in the Ruby rats has been poorly identified.
Since Rab38 is highly expressed in alveolar type II cells (22) as well as melanocytes and platelets (13, 17, 29) , Rab38 deficiency appears to cause the HPS lung phenotype that is closely related to abnormalities in type II cells and their lung surfactant metabolism. Chocolate mice, carrying another Rab38 mutation, showed altered lung surfactant homeostasis and alveolar structural derangement (23) . These mice have oculocutaneous albinism but not bleeding diathesis, and hence it has been questioned whether they are an animal model of HPS. Thus whether the lung phenotype is closely related to HPS is not clear until lung changes in Ruby rats are clarified. The aim of our current study was to characterize changes of lung surfactant metabolism in the Rab38-deficient rats and to investigate their mechanism.
MATERIALS AND METHODS
Reagents. Unless otherwise specified, chemicals were purchased from Sigma (St. Louis, MO) or Wako Chemicals (Osaka, Japan). Rabbit anti-sheep surfactant protein B (SP-B), rabbit anti-mouse SP-D, and mouse anti-rabbit GAPDH antibody were sourced from Chemicon (Temecula, CA). Mouse anti-rat SP-A antibody (1D6) were produced in the National Jewish Medical and Research Center (Denver, CO). Horseradish peroxidase-conjugated goat anti-rabbit IgG antibody, anti-mouse IgG antibody, and a broad range of prestained SDS-PAGE molecular marker were obtained from Bio-Rad (Hercules, CA). A chemiluminescent detection kit, a stripping buffer, and a microbicinchoninic acid (BCA) protein assay kit were purchased from Pierce (Rockford, IL). TLC apparatus was purchased from Advantech (Tokyo, Japan), and Silica Gel G plates were sourced from Analtech (Uniplate; Newark, DE). Human SP-A was a generous gift from Dr. Yoshio Kuroki (Sapporo Medical University).
Rats. All animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee of Kanazawa Medical University. Specific pathogen-free male Sprague-Dawley (SD), LongEvans/Kwl (LE), and LE Cinnamon/Crj (LEC) rats were purchased from Japan Charles River (Yokohama, Japan). The genotypes of the rats were determined by sequencing of PCR products of Rab38 exon 1. Rab38 primer pairs were designed to amplify exon 1: forward primer (5Ј-AAGCTCCAGGCTCCGCAAGA-3Ј) and reverse primer (5Ј-CCTCTCACTGTCCCATTCCAC-3Ј). DNA sequencing of Ruby mutation was confirmed in reverse direction by using the primer 5Ј-GTCTTGCCTACACCTAGGTC-3Ј (18) and a BigDye Terminator Cycle Sequencing Kit (PE Applied Biosystems, Foster City, CA). Bleeding time was measured as described previously (4) .
Lung histology and morphometry. Male LE and male LEC rats at 10 -13 wk old and of similar body weights were used. Rats were killed under intraperitoneal anesthesia with sodium pentobarbital (ϳ100 mg/kg body wt) plus sodium heparin (ϳ3,300 U/kg body wt). The lungs were carefully inflated with 10% formalin neutral buffer solution via the trachea at a constant hydrostatic pressure of ϩ25 cmH 2O at the height of the carina in the upright position. After fixation, the lung volume was measured by water displacement. The right lung was cut into 5-m thick sections in the sagittal plane so as to contain the largest lung area. Care was taken to cut the fixed lungs at the same thickness without any distortion. The lung slices were stained using hematoxylin and eosin (H&E). An imaginary rectangle of which the 4 sides touched the outline of a lung slice was defined on a microscope stage and was divided into Ͼ40 fields of the same size. Each field was photographed at 295 ϫ 223 m 2 and contained 35 equidistant test points. Two test lines connecting the opposite angle, both 370 m in length, were drawn on the field. Large airways and vessels were excluded from the analysis. Based on the lung morphometric method (23, 30) , the mean linear intercept (Lm), which represents average interalveolar distance, was calculated.
Electron microscopy. Male rats at 9 wk old (LE and LEC) were killed, and freshly excised lungs were cut into small pieces and fixed for 2 h with fresh fixative containing 2.5% glutaraldehyde-0.1% picric acid-2% osmium tetroxide-4% sucrose-0.1 M cacodylate buffer (pH 7.4). The blocks were postfixed with 1% aqueous uranyl acetate solution for 1 h followed by dehydration in a graded series of ethanol and subsequent propylene oxide and were finally embedded in Epon. Semithin sections (0.8-m thick) were prepared and stained with 1% toluidine blue with warming. Ultrathin sections (60-nm thick) were then counterstained with 2% uranyl acetate followed by 2.66% lead nitrate-3.52% sodium citrate (pH 12). The sections were examined using a Hitachi H-7100 transmission electron microscope.
Preparation of BAL fluids, lamellar bodies, and lung homogenates. Male rats at 8 -10 wk old (LE and LEC) and of similar body weight were used. Five milliliters of saline-10 mM HEPES (pH 7.4) was infused into the trachea and gently recovered. This procedure was repeated four times and yielded ϳ24.5 ml of lavage fluid. The cell-free bronchoalveolar lavage (BAL) fluids were concentrated to a 0.5-ml volume with a centrifugal filter (5,000 molecular weight cutoff). The right lung was cut into small pieces and homogenized with a Potter-Elvehjem-type homogenizer. Discontinuous sucrose density gradients were centrifuged at 100,000 g for 3 h (19, 21) . The 0.4 -0.6 M layers were recovered as the lamellar body fraction, diluted, and centrifuged at 100,000 g for 1 h to pellet the lamellar bodies. The pellet was divided into two and used for Western blot and lipid extraction/phosphorus assay. One-half of the left lung tissue was cut into small pieces, dissolved in 0.5 ml of 1% Triton X-100-0.9% NaCl-50 mM HEPES (pH 7.4)-1.5 mM EGTA-antiproteases (10 g/ml aprotinin, 10 g/ml leupeptin, and 1 mM PMSF), and was homogenized with a Potter-Elvehjem-type homogenizer, followed by centrifugation at 300 g for 10 min. The supernatant was then centrifuged at 100,000 g for 30 min. The supernatant was used for Western blotting. The remaining half of the left lung tissue was cut into small pieces and used for lipid extraction/phosphorus assay.
Western blotting. Fixed amounts of samples were subjected to 4 -12% Bis-Tris SDS-PAGE under reducing conditions and transferred to a nitrocellulose membrane. The membrane was immunoblotted with a rabbit anti-rat Rab38 antibody, a rabbit (or mouse) anti-surfactant protein antibody, or a mouse anti-GAPDH antibody followed by incubation with a horseradish peroxidase-conjugated goat anti-rabbit (or anti-mouse) IgG antibody. Chemiluminescent detection assay was carried out, and bands were developed using an autofluorography film. Exposure times were adjusted to between 15 s and 5 min (usually 1 min) depending on the obtained signal intensities.
Phospholipid assay. Total lipids were extracted according to the method of Bligh and Dyer (3) from one of the two cell-free BAL fluids, the two lamellar body fractions, and the two left lung homogenates. In all cases, 20% of each sample was used for phospholipid phosphorus content determination with the method described by Bartlett (2) . The remaining 80% of each sample was used for twodimensional thin-layer chromatography (24) . After development, the silica gel spot corresponding to phosphatidylcholine motility was scraped off and recovered quantitatively. The phosphorus content was then quantified.
[ 3 H]phosphatidylcholine secretion. Male SD or LE rats were used as controls, and male LEC rats were used as Rab38-deficient rats. Type II cells were isolated from the rats by tissue dissociation with elastase and metrizamide density gradient centrifugal separation as previously described (19, 21) . Isolated cells were plated in 35-mm plastic culture dishes at 2 ϫ 10 6 cells in 2 ml of DMEM containing 10% FBS and 0.5 Ci/ml [ 3 H]choline chloride (American Radiolabeled Chemicals, St. Louis, MO) and incubated in a 10% CO 2 incubator at 37°C for 20 -22 h. An amount of 1.8 ml of DMEM at 37°C was added to the adherent cells and incubated for 15 min and, when indicated, followed by the addition of agonists or antagonists, TPA (100 nM), ATP (10 M), terbutaline (100 M), or rat SP-A (1 g/ml). Phospholipid secretion was allowed to proceed for 3 h. The supernatant medium and cells were separated, and the lipids were extracted according to the method of Bligh and Dyer (3). Lactate dehydrogenase (LDH) release was evaluated with a LDH Cytotoxicity Detection Kit (Clontech, Mountain View, CA).
Gene expression assay. Using an RNeasy Mini Kit (Qiagen, Valencia, CA), total lung RNA was extracted from ϳ100 mg of peripheral lung slice that was previously treated with an RNAlater (Ambion, Austin, TX). Disruption and homogenization of the lung tissues were performed with a rotor-stator homogenizer. RNase-free DNase I treatment was included in the procedure. Complementary DNA was synthesized with a SuperScript III kit (Invitrogen, Carlsbad, CA) including RNase H treatment. Real-time PCR assay was performed by ABI 7700 thermal cycler (PE Applied Biosystems). TaqMan Gene Expression Assay kit and TaqMan Universal PCR Master Mix were used for analysis of mRNA expression levels of SP-A, -B, -C, -D, and GAPDH.
Liposome uptake assay. Freshly isolated alveolar type II cells were seeded in 12-well plastic plates at a density of 1 ϫ 10 6 cells/well. Next day, according to the method described before (27) , liposome mixtures [1,2-dipalmytoyl-2-linoleoyl-L-3-phosphatidylcholine, egg phosphatidylcholine, L-␣-phosphatidyl-DL-glycerol, and cholesterol (60:20: 15:5 by weight)] were dissolved in chloroform-methanol (2:1 vol/vol) in a concentration of 10 mg/ml. To 0.25 ml of the lipid mixture, 12.5
3 H]phosphatidylcholine (American Radiolabeled Chemicals) was added and dried under nitrogen gas. The dried lipid mixture was redissolved in 2.5 ml of PBS (1 mg phospholipid/ml) and sonicated until the solution become clear. DMEM (0.5 ml)-1% BSA with or without human SP-A (2.5 g/ml) was added to the cells followed by an addition of 50 l of the radiolabeled liposome. The cells were allowed to incorporate for 2 h.
Statistics. Data were expressed as means Ϯ SE and were statistically evaluated using Student's t-test with StatView software (Abacus Concepts, Berkeley, CA). P Ͻ 0.05 was considered statistically significant.
RESULTS
The phenotype of LEC rats. Several substrains of LE rats including FH, TM, and LEC rats show oculocutaneous albi-nism. Although FH and TM rats are known to show elongation of bleeding time as well as oculocutaneous albinism, it has not been reported previously that LEC rats develop bleeding diathesis. The bleeding time was significantly elongated in LEC rats of 12-wk-old (all Ͼ 15 min) than in the control rats of the same age (2 min 25 s Ϯ 43 s; P Ͻ 0.05; n ϭ 4). There was no significant difference in peripheral blood platelet number between SD rats and LEC rats (SD: 29.3 Ϯ 1.4 ϫ 10 4 /l; LEC: 28.3 Ϯ 0.8 ϫ 10 4 /l; means Ϯ SE, n ϭ 3). Thus the phenotype of LEC rats is consistent with that of animal model of HPS. Although the Ruby point mutation occurs in the initiation codon of Rab38 exon 1, and presumably disrupts the translation of the Rab38 protein, there is little report that Ruby rat lungs actually lack this protein. Figure 1 shows that LEC lung homogenates completely lack Rab38 protein expression.
Enlarged distal airway spaces are evident in LEC rat lungs. LEC rat lungs showed uniformly enlarged distal airway spaces ( Fig. 2A) . Quantitative lung morphometry was performed on the lung tissue sections (Fig. 2B) . The lung volumes normalized by body weight were significantly larger in LEC than in control rats (3.07 Ϯ 0.01 vs. 2.67 Ϯ 0.01 ml/100 g body wt, means Ϯ SE; P Ͻ 0.05). The Lm, which reflects average alveolar size including alveolar wall and lumen, was significantly larger in LEC than control rat lungs. These results are consistent with a previous report that FH rats, another strain of Ruby rats carrying a Rab38 deficiency, show distal air space enlargement accompanied by increased lung distensibility at an early age, which does not progress in an age-dependent manner (15) .
Giant lamellar bodies are present in type II cells of Rab38-deficient rats. Before examining lung tissues by an electron microscopy, lung pieces fixed and embedded in Epon were cut into semithin 0.8-m sections and stained with 1% toluidine blue to observe a larger area of alveolar tissue (Fig. 3A) . A number of type II cells in LEC rat alveoli contained remarkably larger cytoplasmic granules compared with the control rats. Ultrathin 60-nm sections were prepared and examined by a transmission electron microscopy. Type II cells in LEC rats revealed the presence of peculiar giant lamellar bodies (Fig.  3B) . However, despite their larger sizes, these lamellar bodies appeared to be ultrastructurally normal.
Altered lung surfactant pool in LEC rat lungs. Lamellar body fractions were isolated from lavaged and homogenized rat lungs using sucrose density gradient centrifugation. Lung surfactant pellets of larger volume sizes were recovered from LEC rats compared with the control rats of equivalent body weight (Fig. 4A) . The phosphatidylcholine contents were analyzed using two-dimensional thin-layer chromatography. Phosphatidylcholine was increased in the lamellar body fraction and the lung homogenate from LEC rats but was similar in the BAL fluids (Fig. 4B) . SP-A, SP-B, and SP-D levels were quantified in these fractions by Western blotting and densitometry (Fig. 5A) . Although the loaded sample volumes were equivalent in each fraction between the control and LEC, the sample volumes were different among the different fractions (lamellar body, lung homogenate, and BAL). Thus densitometric scanning intensities were calculated based on the ratio of the loaded sample volume to the total sample volume (Fig. 5B) . SP-A was decreased in the lamellar body fraction, the lung homogenate, and the BAL fluid in LEC rats. SP-B was increased in the lamellar body and lung homogenate but contrarily decreased in the BAL fluid in LEC lungs. SP-D was readily detectable in the BAL fluid but not in the present sample amounts of lung Fig. 1 . Long-Evans (LE) Cinnamon (LEC) rats lack Rab38 protein expression. Perfused blood-free left lungs were minced, homogenized, and solubilized. Equivalent amount (80 g of protein) of the samples were subjected to SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was immunoblotted with a rabbit anti-rat Rab38 antibody followed by a horseradish peroxidase-conjugated goat anti-rabbit IgG antibody. After stripping off the antigen-antibody complex, the membrane was immunoblotted again with a mouse anti-GAPDH antibody for evaluating sample amounts. Each lane corresponds to an independent rat. Fig. 2 . LEC rat lungs show uniformly enlarged distal air spaces. A: LE and LEC rats at 10 -13 wk old and of similar body weights were used. The rat lungs were inflated with a fixative via the trachea at a ϩ25-cmH2O pressure. The fixed lungs were cut in a sagittal plane so as to contain the largest right lung area and stained with hematoxylin and eosin (H&E). The same portion of the right lungs was photographed. Bars, 200 m. Original magnification, ϫ40. B: lung morphometry was performed on 4 independent rat lungs in each group. The mean linear intercept normalized by body weight was significantly larger in the LEC rats compared with the control rats. **P Ͻ 0.001 (n ϭ 4).
homogenates. There was no significant difference between the control and LEC in the SP-D levels of the BAL fluids. Despite these different surfactant protein expression levels in the lung tissues between the control and LEC, there was no significant difference of mRNA expression levels for SP-A, SP-B, SP-C, and SP-D (Fig. 6 ). (Fig. 7A) . A: increased recovery of lamellar body fraction from LEC rats. Lamellar body fractions were isolated from lavaged and homogenized rat lungs using sucrose density gradient centrifugation. The fractions were pelleted and photographed. Each pellet corresponds to a whole lamellar body fraction recovered from an individual rat right lung. B: total phosphatidylcholine levels in the lamellar body fraction, the lung homogenate, and the bronchoalveolar lavage (BAL) fluid from a rat. Phosphatidylcholine was measured by 2-dimensional TLC. **P Ͻ 0.01, ***P Ͻ 0.001 vs. control (n ϭ 6). LB, lamellar body; LH, lung homogenate. Note the different magnitude of a vertical scale.
Aberrant secretion of newly synthesized
Rab38-deficient type II cells showed significantly lower basal secretion (Fig. 7B) . However, the agonist-induced secretion of [ 3 H]phosphatidylcholine from Rab38-deficient type II cells was remarkably amplified compared with the control cells (Fig.  7C ). In the Rab38-deficient cells, the magnitude of the secretory stimulation was similar to the control cells, i.e., TPA Ͼ ATP Ͼ terbutaline. Treatment with human SP-A effectively inhibited both basal and TPA-induced secretions. The LDH release into the medium did not exceed 3% of the total cellular content in all experiments.
Liposome uptake by type II cells is not altered. Isolated and cultured type II cells were incubated with liposomes including [ 3 H]phosphatidylcholine and were allowed for incorporation into the cells for 2 h. There was no significant difference of and D signals were determined by densitometry, and the total levels were calculated based on the ratio of the loaded sample volume to the total sample volume. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 vs. control (n ϭ 6). Note the different magnitude of a vertical scale. AU, arbitrary units.
liposome incorporation between the control and the Rab38-deficient type II cells (Fig. 8) . Exogenously added human SP-A enhanced the liposome uptake, but the effect was inhibited at 4°C.
DISCUSSION
HPS comprises a group of related autosomal recessive diseases that are genetically heterogeneous. There are 16 mouse homologs of human HPS that manifest oculocutaneous albinism and bleeding diathesis (12) . Among them, 8 genetically distinct forms of HPS have so far been identified in humans (HPS1-8). In contrast, only 2 HPS animal models have been described in rats; FH and TM (18, 25) . Ruby mutation occurs in the initiation codon of Rab38 exon 1, which presumably confers a protein-null defect (18) as shown in Fig. 1 . Most of the genetic products identified in these variant forms of HPS participate in vesicle trafficking that is related to lysosomerelated organelles, as they are involved in the biogenesis of lysosome-related organelle complexes (BLOC) -1, -2, and -3 (6, 12, 29) . In rats, Rab38 mRNA and protein are expressed predominantly in the lung and the skin (20) . Melanocytes and type II cells contain lysosome-related organelles that consist of melanosomes in melanocytes (5, 6, 29) and lamellar bodies in type II cells (28) . It is likely that Rab38 participates in biogenesis/transport of lamellar bodies, i.e., lysosome-related organelles in the lung.
Several LE rat substrains carry Ruby phenotype (18) . Among them, FH rats have been investigated most frequently because of their interesting lung phenotype, i.e., pulmonary hypertension. Also, the morphological and functional study performed before the identification of Rab38 showed distal air space enlargement and increased lung distensibility without obvious alveolar destruction in FH rats, which occur at an early age and do not progress with age (15) . However, no report on lung surfactant system has ever been available. In preliminary study, we observed an electron microscopic feature of FH rat lungs and found enlarged lamellar bodies similar to LEC rats (data not shown). FH rats carry several other genetic abnormalities and develop pulmonary hypertension, systemic hypertension, renal failure, and alcoholism (18) . Among the Ruby rats, we used LEC rats because it was easier to purchase them regularly from the laboratory animal supplier in Japan. LEC rats carry another genetic mutation in ATP7B gene, encoding copper transporter ATPase, and develop hepatitis at ϳ20 wk of age and hepatocellular carcinoma at ϳ18 mo of age (31) . Hence, LEC rats are a rat model of Wilson disease. However, there is no report that ATP7B mutation affects alveolar type II cell function. No specific relationship between Wilson disease and lung disease has been reported. Thus it is likely that the observed lung changes in LEC rats are related to Rab38 mutation.
In this study, we observed that Rab38-deficient LEC rat lungs show giant lamellar bodies in type II cells and increased phosphatidylcholine and SP-B as reported in other animal models of HPS (14) . The beige mice, a model of ChediakHigashi syndrome that is closely related to HPS, also show similar phenotype of type II cells and lamellar bodies (26) . However, abnormal cytoplasmic inclusion body, which is a characteristic feature of beige mice, was not observed in LEC peripheral blood leukocytes (data not shown). The lung involvement in HPS patients is characterized by usual interstitial pneumonia (UIP)-like interstitial pneumonia (16) . However, rodent models of HPS develop hyperinflationary lungs (14, 15, 23) as seen in this study (Fig. 2) instead of fibrotic lungs, although its mechanism is not clarified yet. The prominent pathological features of the lung tissues of HPS patients are alveolar septa displaying florid proliferation of type II cells with characteristic foamy swelling/degeneration (16) . Those peculiar type II cells are histochemically characterized by overaccumulation of phospholipid and ultrastructurally by the presence of numerous giant lamellar bodies, together suggest- Fig. 6 . Messenger RNA levels for surfactant proteins A, B, C, and D are not different between control and Rab38-deficient rat lungs. Total RNA was extracted from control and Rab38-deficient rat lungs, rat alveolar macrophages, and freshly isolated type II cells. Complementary DNA was synthesized using oligo(dT)20 primers. Real-time PCR assay was performed using TaqMan Gene Expression Assay kit for analysis of mRNA expression levels of SP-A, -B, -C, -D, and GAPDH. Messenger RNA levels of GAPDH were used to normalize each surfactant protein expression level. There was no significant difference between control and Rab38-deficient rats (n ϭ 6 of separate experiments performed in duplicate). Messenger RNA of alveolar macrophages (AM) and type II cells (TII) from Sprague-Dawley rats were used as negative and positive control, respectively, and were not subjected to statistical analysis. Cont, control.
ing a form of cellular degeneration with an overaccumulation of surfactant (giant lamellar body degeneration). It is likely that giant lamellar bodies play an important role in the development of HPS lung phenotype. This phospholipid overloading and the peculiar morphology of type II cells in human HPS lungs are similar to those we observed in the LEC lungs in the current analysis. These results support the idea that Rab38 deficiency will develop the HPS lung phenotype. Chocolate mice have been shown to carry another Rab38 mutation (13) , thus establishing that rat Ruby and mouse chocolate genes are homologs. The chocolate mutation occurs in the conserved GTP/GDP-interacting domain and causes a Gly19Val substitution in the Rab38 protein (13) . Indeed, chocolate mice also show altered homeostasis of lung surfactant and aberrant morphology of alveolar type II cells similar to LEC rats (23) . However, chocolate mice manifest only oculocutaneous albinism and not bleeding disorder. For this reason, chocolate mice have not been grouped in mouse models of human HPS. In this regard, it was not clear until this study whether the lung phenotype caused by the chocolate mutation is closely related to HPS lung phenotype. The similarity between the lung phenotypes of chocolate mice and LEC rats confirms that the lung phenotype belongs to animal model of HPS and the underlying cause is Rab38 abnormality.
Rab38 is specifically expressed in type II and Clara cells in rat lungs (20) . Type II cells synthesize, store, secrete, and recycle lung surfactant. Although Rab38-mutated type II cells develop giant lamellar bodies as shown in this study and in our previous report (23), Rab38 is not present in the lamellar body-rich fraction of type II cells (20 (Fig. 8) . These results support the idea that Rab38 deficiency does not affect both synthesis and uptake of lung surfactant.
Lung surfactant is a complex of several lipids (mainly phosphatidylcholine) and four surfactant apoproteins, SP-A, -B, -C, and -D (8) . Phosphatidylcholine, SP-B, and SP-C are hydrophobic surfactant constituents, whereas SP-A and SP-D are hydrophilic. There is growing evidence that there are different intracellular transport pathways for each surfactant component. With the exception of SP-D, these surfactant components are stored in lamellar bodies. SP-D is synthesized and transported to the Golgi apparatus and then constitutively secreted but is not routed to the lamellar bodies (7). Thus the major pool of SP-D is present in BAL fluid. Rab38 does not appear to participate in SP-D trafficking (Fig. 5) . Newly synthesized SP-A is transported to the Golgi apparatus and undergoes glycosylation and is then constitutively secreted (19) . A portion of the secreted SP-A is subsequently transported into lamellar bodies. However, SP-A is not enriched in lamellar bodies in the same manner as phosphatidylcholine and SP-B. For these multiple transport steps, the reason for the decreased SP-A in lamellar body fraction, lung homogenate, and BAL fluid (Fig. 5) in LEC rats despite equal mRNA levels (Fig. 6 ) is currently unknown.
Phosphatidylcholine and SP-B are primarily stored in lamellar bodies before secretion. Phosphatidylcholine is a major component of lamellar bodies. Newly synthesized phosphatidylcholine is transported to and stored in lamellar bodies via a Golgi-independent pathway (21) . Newly synthesized SP-B is transported to the Golgi apparatus and then to the lamellar bodies where it is stored (11) . Phosphatidylcholine and SP-B were increased in lamellar body fraction but not in BAL fluid (Figs. 4B and 5) , and giant lamellar bodies fulfilled alveolar type II cell cytoplasm in LEC rats (Fig. 3) . Given that alveolar type II cells of LEC rats contain enlarged giant lamellar bodies and that phosphatidylcholine and SP-B levels are increased in these cells but not in the BAL fluid, it is likely that secretory machinery of lamellar bodies is malfunctioning due to loss of Rab38 function.
To test whether secretion of lamellar bodies is suppressed in Rab38-deficient type II cells, we investigated secretory activity of newly synthesized [ 3 H]phosphatidylcholine from these cells. As expected, basal secretion was inhibited in LEC type II cells (Fig. 7B) . However, agonist-induced secretion was contrarily amplified in LEC cells (Fig. 7C) . There are multiple intracellular signaling pathways for phosphatidylcholine secretion in type II cells including protein kinase A, protein kinase C, and Ca 2ϩ /calmodulin-dependent protein kinase (1) . Most pathways seem to be equally amplified by agonist-induced secretion in Rab38-deficient type II cells, since the order of this stimulus magnitude was similar to normal type II cells (TPA Ͼ ATP Ͼ terbutaline). Exogenously added human SP-A effectively inhibited the TPA-stimulated secretion as already reported. These results suggest that Rab38-deficient type II cells sustain inhibited lamellar body secretion and develop larger size of lamellar bodies without stimuli and that, in contrast, these cells may secrete a larger amount of lamellar bodies on certain kinds of stimuli. It is not clear that these dual responses of lung surfactant secretion are seen in other HPS type II cells. Type II cells from the mouse model of HPS, double mutant ep/pe, showed both lower basal and agonist-induced secretion (9) . However, double mutations may cause highly serious dysfunction in type II cells. Thus it is still unclear whether secretion from HPS type II cells on certain stimuli is suppressed or enhanced, although basal secretion appears to be suppressed.
In summary, Rab38-deficient rats develop abnormal lung surfactant homeostasis and lamellar body morphology. Aberrant secretion but not synthesis or recycling of lung surfactant appears to cause these abnormalities in type II cells.
